Notice of National Cancer Institute (NCI) Participation in PA-14-155 "Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R01)"

Notice Number: NOT-CA-14-040

Key Dates
Release Date: March 24, 2014

Related Announcements
PA-14-155

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating, effective immediately, in PA-14-155 "Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R01).”

The following sections of PA-14-155 have been updated to reflect NCI's participation in this funding opportunity announcement.

Part 1. Overview Information

Components of Participating Organizations
National Institute of General Medical Sciences (NIGMS)
National Human Genome Research Institute (NHGRI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
Office of Behavioral and Social Sciences Research (OBSSR)
National Cancer Institute (NCI)

Catalog of Federal Domestic Assistance (CFDA) Numbers
93.859; 93.273; 93.361; 93.121; 97.853; 93.286; 93.865; 93.279; 93.846; 93.172; 93.113; 93.393; 93.394; 93.395; 93.396; 93.399.

Part 2. Section VII. Agency Contacts

Scientific/Research Contact
J. Jerry Li, M.D., Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6210
Email: [email protected]

Financial/Grants Management Contact
Carol Perry
National Cancer Institute (NCI)
Telephone: 240-276-6282
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

J. Jerry Li, M.D., Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6210
Email: [email protected]